Nu Skin Obtains FDA Clearance of Facial Spa Device

              Nu Skin Obtains FDA Clearance of Facial Spa Device

PR Newswire

PROVO, Utah, Sept. 26, 2013

PROVO, Utah, Sept. 26, 2013 /PRNewswire/ --Nu Skin Enterprises, Inc. (NYSE:
NUS) today announced that it has received FDA clearance to market a facial spa
device for over-the-counter cosmetic use. The company's 510(k) application was
filed approximately one year ago. The company estimates that the facial spa
will become available for sale some time during the first half of 2014.

"We have seen great demand for our innovative spa products throughout the
world which has helped us to become a global leader in the home-use skin care
device market," said Joseph Chang, Ph.D., chief scientific officer. "We are
pleased that our U.S. sales leaders and consumers will be able to enjoy the
benefits of this skin care device."

According to a 2012 Kline & Company report, the market for at-home skin care
devices has enjoyed double-digit growth globally, with Nu Skin devices leading
the way in Asia. The report points to even greater opportunities for growth in
the at-home skin care device market in the future.

About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its
comprehensive anti-aging product portfolio, independent business opportunity
and corporate social responsibility initiatives. The company's scientific
leadership in both skin care and nutrition has established Nu Skin as a
premier anti-aging company. The company's anti-aging products feature the new
ageLOC^® suite of products including the ageLOC^® R^2 nutritional supplement,
and ageLOC^® Galvanic Body Spa™, as well as the ageLOC^® Transformation daily
skin care system. A global direct selling company, Nu Skin operates in 53
markets worldwide and is traded on the New York Stock Exchange under the
symbol 'NUS'. More information is available at

Please Note: This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended that represent the
company's current expectations and beliefs. All statements other than
statements of historical fact are "forward-looking statements" for purposes of
federal and state securities laws and include, but are not limited to,
statements of management's expectations and beliefs regarding the availability
for sale of the facial spa in the United States. In some cases, you can
identify these statements by forward-looking words such as "believe,"
"expect," "project," "anticipate," "estimate," "intend," "plan," "targets,"
"likely," "will," "would," "could," "may," "might," the negative of these
words and other similar words. The forward-looking statements and related
assumptions involve risks and uncertainties that could cause actual results
and outcomes to differ materially from any forward-looking statements or views
expressed herein. These risks and uncertainties include, but are not limited
to, the following:(a) any manufacturing issues that delay the availability of
the facial spa for marketing and sale in the United States, and (b) any
regulatory or other issues that impact the availability and marketing of the
facial spa. The forward-looking statements contained herein are further
qualified by a detailed discussion of associated risks set forth in the
documents filed by the company with the Securities and Exchange
Commission.The forward-looking statements set forth the company's beliefs as
of the date that such information was first provided and the company assumes
no duty to update the forward-looking statements contained in this release to
reflect any change except as required by law.

SOURCE Nu Skin Enterprises, Inc.

Contact: Investors, Scott Pond, +1-801-345-2657,, Media, Kara
Schneck, +1-801-345-2116,
Press spacebar to pause and continue. Press esc to stop.